Search results - ORA - Oxford University Research Archive

1 - 9 of 9

1

Journal article

Reactivation of the bacille Calmette-Guerin scar following immune reconstitution during treatment of infant acute lymphoblastic leukemia.

Swinson, S, Hall, G, Pollard, A
2004-02-01

2

Journal article

The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling.

Gaffney, E
2004-04-01

3

Journal article

A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation.

Plummer, R, Lorigan, P, Steven, N, et al.
2013-05-01

4

Journal article

Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.

Balasis, M, Forinash, K, Chen, Y, et al.
2011-05-01

5

Journal article

Application of mobile phone technology for managing chemotherapy-associated side-effects.

Weaver, A, Young, A, Rowntree, J, et al.
2007-11-01

6

Journal article

Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma.

Middleton, M, Hauschild, A, Thomson, D, et al.
2007-10-01

7

Journal article

The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics.

Gaffney, E
2005-05-01

8

Journal article

Modelling chemotherapy resistance in palliation and failed cure.

Monro, H, Gaffney, E
2009-03-01

9

Journal article

Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.

Plummer, R, Jones, C, Middleton, M, et al.
2008-12-01

TO TOP